Search results
Results from the WOW.Com Content Network
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
New Zealand: 4,302,330 83.84% Republic of Ireland ... This template is used to provide data for COVID-19 vaccine, COVID-19 pandemic by country and territory, and ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
An analysis by Global Justice Now revealed that more than 82 percent of COVID-19 vaccines have been purchased by the wealthiest countries, accounting for just 14 percent of the world population ...
Favored distribution of vaccines within one or a few select countries, called "vaccine sovereignty", is a criticism of some of the vaccine development partnerships, [39] [42] such as for the AstraZeneca-University of Oxford vaccine candidate, concerning whether there may be [needs update] prioritized distribution first within the UK and to the ...
COVID-19 vaccine production by country Country Doses (millions) 3 Mar 2021 [1] 31 Jan 2022 [2] China 141.6: 4951.4 European Union 81.0:
In August, China's National Intellectual Property Administration issued the country's first COVID-19 vaccine patent to CanSino. [34] On 16 May 2020, Canadian Prime Minister Justin Trudeau announced Health Canada had approved Phase II trials to be conducted by the Canadian Center for Vaccinology (CCfV) on the COVID-19 vaccine produced by CanSino.
(Reuters) - Global vaccine alliance GAVI said on Wednesday 12 countries in Africa would receive 18 million doses of malaria vaccine over the next two years, expanding access to the shots to nine ...